10-Q: Jackson Financial Q3 Earnings Soar, Boosts Capital Return

Sentiment:

Quarterly Report


Jackson Financial Inc. reported a significant turnaround in Q3 net income and EPS, driven by favorable market risk benefit movements and strong sales growth, while reaffirming its commitment to capital returns.

Better than expectedNet income attributable to common shareholders for Q3 2025 significantly improved to $65 million from a loss of $480 million in Q3 2024.Basic EPS for Q3 2025 improved to $0.93 from $(6.37) in Q3 2024.Adjusted Operating Earnings increased for both the three and nine months ended September 30, 2025, indicating strong underlying business performance.Total sales for the nine months ended September 30, 2025, increased by $2.65 billion, demonstrating robust growth in key product segments.Free capital generation for the nine months ended September 30, 2025, exceeded $1 billion, meeting the company's full-year expectation and indicating strong liquidity.The company expects to exceed its 2025 capital return target to common shareholders, highlighting a strong commitment to shareholder value.

Summary

  • Net income attributable to common shareholders for Q3 2025 was $65 million, a substantial improvement from a net loss of $480 million in Q3 2024.
  • Basic earnings per share (EPS) for Q3 2025 was $0.93, up from $(6.37) in Q3 2024.
  • Adjusted Operating Earnings increased to $433 million in Q3 2025 from $350 million in Q3 2024.
  • Total sales for the nine months ended September 30, 2025, increased to $17,305 million from $14,653 million in the prior year, driven by RILA, variable annuity, and institutional product sales.
  • Assets Under Management (AUM) grew to $350.3 billion as of September 30, 2025, from $324.7 billion at December 31, 2024.
  • Free capital generation for the nine months ended September 30, 2025, exceeded $1 billion, meeting the company's full-year expectation.
  • The Board of Directors authorized a $1 billion increase in the share repurchase program on September 18, 2025, with $1.1 billion remaining authorization as of October 24, 2025.
  • The company returned $657 million to common shareholders through dividends ($173 million) and share repurchases ($484 million) for the nine months ended September 30, 2025, and expects to exceed its full-year capital return target of $700-$800 million.
  • Net income attributable to common shareholders for the nine months ended September 30, 2025, decreased to $198 million from $568 million in the prior year, primarily due to unfavorable market risk benefit movements and hedging results.
  • Total revenues for Q3 2025 decreased to $1,416 million from $2,121 million in Q3 2024, while total benefits and expenses significantly decreased to $1,344 million from $2,700 million.
  • The effective income tax rate was (32.4)% for Q3 2025 and (6.4)% for the nine months ended September 30, 2025, compared to 19.3% and 3.9% for the same periods in 2024, respectively.

Sentiment

Score: 7

Explanation: The company demonstrated strong operational performance and significant improvement in quarterly net income and EPS, driven by favorable market risk benefit movements and robust sales growth. While year-to-date net income declined due to hedging volatility, adjusted operating earnings and capital returns remain strong and are expected to exceed targets. The strategic initiatives like the Brooke Re transaction are positively impacting capital management. The overall outlook is positive, despite ongoing market and regulatory risks.

Positives

  • Net income attributable to common shareholders significantly improved to $65 million in Q3 2025 from a loss of $480 million in Q3 2024.
  • Basic EPS for Q3 2025 improved to $0.93 from $(6.37) in Q3 2024.
  • Adjusted Operating Earnings increased by $83 million to $433 million in Q3 2025 and by $65 million to $1,159 million for the nine months ended September 30, 2025.
  • Total sales increased by $2.65 billion for the nine months ended September 30, 2025, reaching $17.3 billion, driven by strong RILA, variable annuity, and institutional product sales.
  • Assets Under Management (AUM) increased by $25.6 billion to $350.3 billion as of September 30, 2025, reflecting favorable equity market performance and sales growth.
  • Free capital generation exceeded $1 billion for the nine months ended September 30, 2025, meeting the company's full-year expectation.
  • The company expects to exceed its 2025 capital return target of $700-$800 million to common shareholders, having already returned $657 million by September 30, 2025.
  • The share repurchase program was increased by $1 billion on September 18, 2025, demonstrating confidence in capital position and commitment to shareholder returns.
  • The Brooke Re transaction, effective January 1, 2024, is largely moderating the impact of the cash surrender value floor on statutory capital, optimizing hedging, stabilizing capital generation, and producing more predictable financial results.

Negatives

  • Total revenues decreased to $1,416 million in Q3 2025 from $2,121 million in Q3 2024, primarily due to unfavorable net gains/losses on derivatives and investments.
  • Net income attributable to common shareholders for the nine months ended September 30, 2025, decreased to $198 million from $568 million in the prior year, largely due to unfavorable market risk benefits (gains) losses, net.
  • Basic EPS for the nine months ended September 30, 2025, decreased to $2.76 from $7.41 in the prior year.
  • Net flows, net of reinsurance, remained negative at $(8,917) million for the nine months ended September 30, 2025, although an improvement from $(12,010) million in the prior year.
  • Elevated variable annuity surrenders and withdrawals were driven by mature policies exiting surrender charge periods and guaranteed benefits being less 'in the money' during strong equity markets, alongside higher interest rates and attractive annuity alternatives.

Risks

  • Macroeconomic and Financial Market Conditions: Government actions, market volatility, equity market declines, and interest rate movements can adversely affect financial performance, sales, and hedging costs.
  • Hedge Effectiveness: Hedges may be less effective in periods of large directional market movements or high volatility, leading to increased rebalancing costs and adverse performance against hedge targets.
  • Basis Risk: Inability to purchase or sell hedge assets that fully correlate to customer fund performance can lead to mismatches in hedge results.
  • Interest Rate Environment: Periods of rising or falling interest rates and volatility can impact hedging costs, product attractiveness, sales volumes, regulatory reserves, net investment spread, and disintermediation risk.
  • Credit Market Environment: Widening credit spreads decrease investment portfolio fair value, while deteriorating credit conditions could lead to increased defaults, other-than-temporary impairments (OTTI), and negative impacts on regulatory capital and RBC ratios.
  • Consumer Behavior: Economic uncertainty, unemployment, declining equity markets, and significant changes in interest rates can impact demand for products and policyholder behavior.
  • Regulatory Policy: New federal and state regulations, such as the Department of Labor Fiduciary Advice Rule, could impact the business model, sales of annuities, and increase compliance costs and litigation risk.
  • Tax Laws: Changes to U.S. tax laws, particularly those affecting tax deferral advantages of annuities, could materially decrease demand for products.
  • Valuation Allowance: A valuation allowance of $470 million was established on a portion of the deferred tax asset related to unrealized losses in available-for-sale securities and charitable contributions carryover, indicating uncertainty in realizing the full tax benefit.

Future Outlook

The company expects to exceed its 2025 capital return target for common shareholders of $700-$800 million. Free capital generation for 2025 is anticipated to exceed $1 billion under normal market conditions. The U.S. Treasury Department is expected to issue additional guidance in 2025 or later that may materially change the estimated provision of the corporate alternative minimum tax ('CAMT'). Demographic trends in the U.S. population, particularly the increase in retirement-age individuals, are expected to generate significant demand for the company's products.

Management Comments

  • We believe that we are uniquely positioned in our markets because of our differentiated products, well-known brand and disciplined risk management.
  • Our core strengths enable us to grow profitably as an aging U.S. population transitions into retirement.
  • Our core dynamic hedging program seeks to offset impacts of equity market and interest rate movements on the economic liabilities associated with variable annuity guaranteed benefits and with annuities subject to index interest crediting (RILA and FIA), while our macro hedging program seeks to provide additional liquidity and statutory capital protection as needed.
  • The Brooke Re transaction enables us to largely moderate the impact of the cash surrender value floor on Jackson's total adjusted capital, statutory required capital, and RBC ratio and enable more efficient economic hedging of the underlying risks of Jackson's business.
  • Overall, this transaction allows us to optimize our hedging, stabilize capital generation, and produce more predictable financial results going forward.
  • Sales of our fixed annuities remain strong as PPM America has added capabilities to source higher yielding assets supporting our spread based products.
  • The increase in JNAM AUM primarily reflects favorable equity market performance.

Industry Context

The company operates in a highly regulated financial services industry, particularly in the U.S. annuity and life insurance markets. It is influenced by macroeconomic factors such as equity market performance, interest rate environments, and credit market conditions. The company notes that higher interest rates and attractive annuity alternatives, such as RILA, combined with its seasoned out-of-the-money book, heighten exchange activity for itself and the industry. Demographic trends, specifically the aging U.S. population, are expected to drive significant demand for retirement planning products. Regulatory changes, such as the Department of Labor Fiduciary Advice Rule, and legislative reforms like the SECURE Act and SECURE 2.0, are shaping the competitive and operational landscape, potentially impacting product offerings and distribution. The company's strategy of opportunistically acquiring mature blocks of life insurance policies is a response to market dynamics, aiming for more efficient diversification than selling new life insurance products.

Comparison to Industry Standards

  • The company's RBC ratio is well in excess of minimum required capital levels, indicating strong statutory capital compared to industry regulatory standards.
  • The Brooke Re transaction is noted to largely moderate the impact of the cash surrender value floor, a common industry challenge for insurers with variable annuity products, by increasing alignment between assets and liabilities in response to economic factors.
  • The company's sales of fixed annuities remain strong as PPM America has added capabilities to source higher yielding assets, suggesting competitive positioning in spread-based products.
  • Elevated variable annuity surrenders and withdrawals are noted as being driven by factors affecting the broader industry, such as mature policies coming out of surrender charge periods and the appeal of alternative products in a higher interest rate environment.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
AssociateScott RomineN/AAugust 5, 2025Separation from employment with Jackson National Life Distributors, LLC.
RetireeMarcia WadstenN/ASeptember 26, 2025Retirement from employment with Jackson National Life Insurance Company.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy UpdateMinisterial amendments to the Jackson Financial Inc. Insider Trading Policy.September 17, 2025Clarifying and ministerial changes throughout, approved by JFI Audit Committee. No material change to core policy.
Policy UpdateMinisterial changes to the Jackson Financial Inc. Compensation Clawback Policy.September 17, 2025Clarifying and ministerial changes throughout, approved by JFI Compensation Committee. No material change to core policy.

Legal Proceedings

  • The company and its subsidiaries are involved in litigation arising in the ordinary course of business, with management believing the ultimate disposition will not have a material adverse effect on financial condition.
  • Jackson has been named in civil litigation proceedings substantially similar to other class action litigation against life insurers, alleging misconduct in the sale of insurance products. The company accrues for legal contingencies when probable and reasonably estimable.

Related Party Transactions

  • Investment fees paid by Jackson Financial and its subsidiaries to PPM (an investment management subsidiary) were $28 million and $21 million for the three months ended September 30, 2025 and 2024, respectively, and $72 million and $60 million for the nine months ended September 30, 2025 and 2024, respectively.
  • The Brooke Reinsurance Company (Brooke Re) transaction, effective January 1, 2024, involves Jackson ceding liabilities to Brooke Re, both direct subsidiaries of Brooke Life Insurance Company. This intercompany transaction eliminates upon consolidation at JFI.
  • Jackson is a member of the FHLBI, requiring purchase and holding of FHLBI capital stock and utilizing its collateralized loan advance program.

Stakeholder Impact

  • Shareholders: Benefited from increased share repurchase authorization ($1 billion increase) and continued common stock dividends ($0.80/share for Q4 2025), with total capital returns expected to exceed targets. Preferred shareholders also receive consistent dividends.
  • Employees: The company reported lower incentive and deferred compensation expenses, which could impact employee compensation. Two executives (Scott Romine and Marcia Wadsten) separated/retired from the company with specific separation/retirement agreements.
  • Customers: Products like RILA and fixed annuities are being introduced/reintroduced to address changing consumer demand. However, elevated variable annuity surrenders and withdrawals indicate some customers are seeking alternatives due to higher interest rates.
  • Regulators: The company is subject to ongoing regulatory scrutiny, including the DOL Fiduciary Advice Rule, and maintains statutory capital well above minimum requirements. The Brooke Re transaction aims to protect statutory capital and stabilize financial results.
  • Creditors: The company maintains access to bank lines of credit and capital markets, with compliance to financial maintenance covenants under its revolving credit facility.

Next Steps

  • The company will apply amendments for ASU 2023-09 (Improvements to Income Tax Disclosures) for the annual period ending December 31, 2025.
  • The company is evaluating the impact of ASU 2024-03 (Reporting Comprehensive Income Expense Disaggregation Disclosures) and ASU 2025-06 (Intangibles Goodwill and Other Internal-use Software) and determining transition methods and timing of adoption.
  • The U.S. Treasury Department is expected to issue additional guidance in 2025 or later that may materially change the estimated provision of the corporate alternative minimum tax ('CAMT').
  • The Board of Directors approved a cash dividend on JFI's common stock of $0.80 per share for Q4 2025, payable on December 18, 2025.
  • The Board of Directors declared a cash dividend of $0.50 per depositary share for Series A Preferred Stock, payable on December 30, 2025.
  • The company expects to continue repurchasing common shares from time to time in the open market or privately negotiated transactions, with $1.1 billion remaining authorization as of October 24, 2025.

Key Dates

DateDescription
March 10, 2023Grant date for 2023 PSU and RSU awards under the 2021 Omnibus Incentive Plan.
February 24, 2023Company replaced its prior revolving credit facility with a new $1.0 billion revolving credit facility, terminating on February 24, 2028.
March 13, 2023Company issued and sold 22,000,000 depositary shares of Series A Preferred Stock.
April 6, 2023Jackson entered into an Uncommitted Money Market Line Credit Agreement for $500 million.
December 1, 2023Effective date of the Compensation Clawback Policy.
January 1, 2024Effective date of the 100% coinsurance with funds withheld reinsurance transaction with Brooke Re.
March 10, 2024Grant date for 2024 PSU and RSU awards under the 2021 Omnibus Incentive Plan.
April 2024Department of Labor (DOL) revised the definition of fiduciary and related Prohibited Transaction Exemptions (2024 Fiduciary Advice Rule).
June 2025Strategic Opportunity Fund I was funded.
July 4, 2025The One Big Beautiful Bill Act ('OBBBA') was enacted, including tax reform provisions effective for the 2025 tax year.
August 5, 2025Scott Romine's last date of employment with Jackson National Life Distributors, LLC.
August 2025Private Equity Fund IX was funded.
September 17, 2025Ministerial amendments approved for Jackson Financial Inc. Insider Trading Policy and Compensation Clawback Policy.
September 18, 2025Board of Directors authorized a $1 billion increase in the common stock share repurchase program.
September 26, 2025Marcia Wadsten's last date of employment with Jackson National Life Insurance Company.
September 30, 2025End of the quarterly reporting period.
October 7, 2025Retirement Agreement signed with Marcia Wadsten.
October 24, 2025Date of common stock outstanding count (67,969,862 shares) and financial strength ratings update.
October 30, 2025Board of Directors approved Q4 2025 cash dividends for common stock ($0.80/share) and Series A Preferred Stock ($0.50/depositary share).
November 4, 2025Filing date of the 10-Q report.
December 4, 2025Record date for Q4 2025 common and preferred stock dividends.
December 18, 2025Payment date for Q4 2025 common stock dividend.
December 30, 2025Payment date for Q4 2025 preferred stock dividend.
December 31, 2025End of performance period for 2023 PSU grant and effective date for new income tax disclosure requirements (ASU 2023-09).
December 15, 2025Effective date for ASU 2025-05 (Financial Instruments Credit Losses).
December 31, 2026End of performance period for 2024 PSU grant.
December 15, 2026Effective date for ASU 2024-03 (Reporting Comprehensive Income Expense Disaggregation Disclosures) for annual periods.
December 31, 2027End of performance period for 2025 PSU grant.
December 15, 2027Effective date for ASU 2024-03 (Reporting Comprehensive Income Expense Disaggregation Disclosures) for interim periods and ASU 2025-06 (Intangibles Goodwill and Other Internal-use Software).
March 30, 2028Reset date for Series A Preferred Stock dividend rate and earliest optional redemption date.

Recommendation

buy

Jackson Financial Inc. demonstrates strong underlying business performance, as evidenced by increased Adjusted Operating Earnings and robust sales growth in key segments like RILA and Institutional Products. While GAAP net income for the nine-month period was impacted by market volatility and hedging accounting, the significant turnaround in Q3 net income and EPS, coupled with management's focus on non-GAAP metrics, suggests effective operational management. The company's commitment to shareholder returns, highlighted by the increased share repurchase program and expected exceeding of capital return targets, signals confidence. The strategic Brooke Re transaction is also expected to stabilize capital generation and provide more predictable financial results. Given the strong operational metrics, capital management, and shareholder-friendly actions, the stock presents an attractive investment opportunity.

Keywords

Jackson Financial, JXN, 10-Q, Quarterly Report, Financial Services, Annuities, Variable Annuities, RILA, Fixed Index Annuities, Institutional Products, Capital Return, Share Repurchase, Dividends, Adjusted Operating Earnings, AUM, SEC Filing, Insurance, Risk Management, Hedging, Market Risk Benefits, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.